Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Haemoglobin and serum iron responses to periodic intravenous iron dextran infusions during maintenance haemodialysis

Producción científica: Article › revisión exhaustiva

Resumen

Patients with chronic renal failure who were on maintenance haemodialysis, were given monthly 600 mg iron intravenously as iron dextran complex to a body replacement total of 5-6 g iron. Those patients who had been on maintenance haemodialysis for a long period and had received numerous blood transfusions failed to show a rise in haemoglobin levels. Those patients who received iron from the commencement of maintenance dialysis, and who had not received blood transfusions, showed a significant increase in haemoglobin concentrations which has been maintained for more than 18 months after iron therapy ceased, despite a concurrent decrease in serum iron concentrations. Pretreatment and post treatment levels of serum iron are not of predictive value for the success of iron treatment, neither for the haemoglobin nor the serum iron response. A body replacement dose of iron given intravenously over a year benefits the majority of patients on maintenance haemodialysis and is recommended for the treatment of their anaemia.

Idioma originalEnglish (US)
Páginas (desde-hasta)121-129
Número de páginas9
PublicaciónNephron
Volumen17
N.º2
DOI
EstadoPublished - 1976
Publicado de forma externaSí

ASJC Scopus subject areas

  • Nephrology
  • Physiology (medical)
  • Urology
  • Physiology

Huella

Profundice en los temas de investigación de 'Haemoglobin and serum iron responses to periodic intravenous iron dextran infusions during maintenance haemodialysis'. En conjunto forman una huella única.

Citar esto